Incyte Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell

46

INCY
Incyte

Last Price:

70.38

Seasonality Move:

50.43%

Buy

57

BMRN
Biomarin Pharmaceutical

Last Price:

61.64

Seasonality Move:

12.47%

Sell

46

Incyte (INCY) is a Sell

Is Incyte a Buy, Sell or Hold?

The current Incyte [INCY] share price is $71.05. The Score for INCY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
INCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

57

Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INCY Stock Price Chart

What is Incyte's stock price today?

The Incyte share price today is $71.05
The current trend is moderately bearish and INCY is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

The Biomarin Pharmaceutical share price today is $62.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

INCY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.74	Buy
Relative Strength Index (14 RSI):	43.55	Sell
Chaikin Money Flow:	254620	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(67.22 - 79.72)	Sell
Bollinger Bands (100):	(60.93 - 72.05)	Buy

BMRN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.16	Sell
Relative Strength Index (14 RSI):	27.46	Sell
Chaikin Money Flow:	863717	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(64.41 - 69.77)	Sell
Bollinger Bands (100):	(68.48 - 87.38)	Sell

INCY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	76.85	Sell
20-day SMA:	75.41	Sell
50-day SMA:	69.53	Buy
200-day SMA:	61.95	Buy
8-day EMA:	75.23	Sell
20-day EMA:	74.74	Sell
50-day EMA:	70.95	Buy
200-day EMA:	64.62	Buy

BMRN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	64.33	Sell
20-day SMA:	66.31	Sell
50-day SMA:	69.39	Sell
200-day SMA:	81.31	Sell
8-day EMA:	63.89	Sell
20-day EMA:	65.94	Sell
50-day EMA:	70.23	Sell
200-day EMA:	79.7	Sell

Incyte Earnings Growth & INCY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Incyte Technical Analysis

	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20
	Nov
	07	08	11	12	13	14	15	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20
	Nov
	07	08	11	12	13	14	15	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):